Harsanyi Zsolt

SEC source: 0001193125-26-343080 · ownership.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · derivative.exercise_date: On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant.

F2 · derivative.expiration_date: On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant.

SEC source: 0001193125-26-343080 · ownership.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

SEC source: 0001380184-26-000005 · wk-form4_1777929828.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,296

Underlying: Common Stock · 11,296 shares

Expires 2033-04-30

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001380184-26-000005 · wk-form4_1777929828.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,076

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0000950170-25-105887 · ownership.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,200

Underlying: Common Stock · 7,200 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · derivative.exercise_date: The RSUs vest in full on the first anniversary of the date of grant.

F2 · derivative.expiration_date: The RSUs vest in full on the first anniversary of the date of grant.

SEC source: 0000950170-25-097283 · ownership.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · derivative.exercise_date: On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant.

F2 · derivative.expiration_date: On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant.

SEC source: 0000950170-25-097283 · ownership.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

SEC source: 0001367644-25-000105 · wk-form4_1746232232.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,572

Underlying: Common Stock · 15,824 shares

Expires 2032-04-29

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-25-000105 · wk-form4_1746232232.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,732

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0000950170-24-084958 · ownership.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 925

Underlying: Common Stock · 925 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · derivative.exercise_date: The RSUs vest in full on the first anniversary of the date of grant.

F2 · derivative.expiration_date: The RSUs vest in full on the first anniversary of the date of grant.

SEC source: 0000950170-24-068073 · ownership.xml · derivative · entry 4

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 81 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F4 · derivative.exercise_date: On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant.

F4 · derivative.expiration_date: On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant.

SEC source: 0000950170-24-068073 · ownership.xml · nonDerivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 280

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · balance_after: On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0000950170-24-068073 · ownership.xml · derivative · entry 3

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F3 · derivative.exercise_date: On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.

F3 · derivative.expiration_date: On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.

SEC source: 0000950170-24-068073 · ownership.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · balance_after: On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001367644-24-000078 · wk-form4_1716945275.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,748

Underlying: Common Stock · 25,748 shares

Expires 2031-05-22

F2 · derivative.exercise_date: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.

F3 · derivative.underlying_shares: The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.

SEC source: 0001367644-24-000078 · wk-form4_1716945275.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,329

F1 · shares: Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

SEC source: 0001209191-23-045301 · doc4.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,571 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · derivative.exercise_date: On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant.

F2 · derivative.expiration_date: On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant.

SEC source: 0001209191-23-045301 · doc4.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

SEC source: 0001209191-23-033828 · doc4.xml · derivative · entry 3

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,571

Underlying: Common Stock · 3,571 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs vest in full on the first anniversary of the date of grant.

F3 · derivative.expiration_date: The RSUs vest in full on the first anniversary of the date of grant.

SEC source: 0001209191-23-033828 · doc4.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298

Underlying: Common Stock · 297 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · derivative.exercise_date: On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.

F2 · derivative.expiration_date: On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.

SEC source: 0001209191-23-033828 · doc4.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

SEC source: 0001367644-23-000104 · wk-form4_1685487864.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director · Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,899

F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

SEC source: 0001209191-22-045182 · doc4.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,571

Underlying: Common Stock · 3,571 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · derivative.exercise_date: The RSUs vest in full on the first anniversary of the date of grant.

F2 · derivative.expiration_date: The RSUs vest in full on the first anniversary of the date of grant.

SEC source: 0001209191-22-033930 · doc4.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595

Underlying: Common Stock · 298 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F3 · derivative.exercise_date: On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.

F3 · derivative.expiration_date: On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.

SEC source: 0001209191-22-033930 · doc4.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2 · balance_after: Shares beneficially owned by the reporting person were adjusted to include the following shares of the Issuer's common stock: (i) 210 shares that were inadvertently omitted from the Form 4 filed on August 5, 2016; and (ii) 527 shares that were originally disclosed in the Form 4 filed on August 5, 2016, but due to a mathematical error, were not included in the aggregate number of shares beneficially owned in the Form 4 filed on June 7, 2019. In each of subsections (i) and (ii) above, the number of shares were adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.

SEC source: 0001367644-22-000094 · wf-form4_165402866909554.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,052

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001019056-21-000357 · harsanyi.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 893

Underlying: Common Stock · 893 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.

F3 · derivative.exercise_date: The RSUs vest in three approximately equal annual installments beginning on June 1, 2022.

F3 · derivative.expiration_date: The RSUs vest in three approximately equal annual installments beginning on June 1, 2022.

SEC source: 0001019056-21-000357 · harsanyi.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,678

Underlying: Common Stock · 2,678 shares

Expires 2031-06-01

F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on June 1, 2022.

SEC source: 0001367644-21-000093 · wf-form4_162189049034879.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,606

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-20-000136 · wf-form4_159775632755761.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,579

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $133.22 to $134.11.

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 5

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170

Underlying: Common Stock · 170 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F7 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant.

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 4

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,322

Underlying: Common Stock · 1,322 shares

Expires 2030-07-26

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F6 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant.

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 3

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,785 shares

Expires 2028-06-01

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F5 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 892 shares

Expires 2027-06-01

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F4 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on June 1, 2018.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

SEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,339 shares

Expires 2026-08-03

F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.

F2 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on August 3, 2017.

F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.

SEC source: 0001019056-21-000143 · harsanyi.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,571

Underlying: Common Stock · 3,571 shares

Expires 2030-07-02

F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on July 2, 2021.

SEC source: 0001367644-20-000072 · wf-form4_159049670609196.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,188

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001367644-20-000068 · wf-form4_158984355155712.xml · derivative · entry 2

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,434 shares

Expires 2021-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Consists of an option granted under the company's stock incentive plan as amended and restated.

F2 · derivative.exercise_date: Vests in three equal installments beginning on the anniversary date of the grant, 5/22/2014.

SEC source: 0001367644-20-000068 · wf-form4_158984355155712.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001367644-20-000063 · wf-form4_158941363023581.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,933

F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.5100 to $82.4150, inclusive.

SEC source: 0001367644-20-000031 · wf-form4_158447754462323.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,873

F1 · security: Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.

SEC source: 0001367644-20-000004 · wf-form4_157929595097570.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,273

F1 · security: Consists of restricted stock units granted the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F2 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Harsanyi.

SEC source: 0001593968-19-001344 · primary_01.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

SEC source: 0001593968-19-001277 · primary_01.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Aptevo Therapeutics Inc. common stock · 25,000 shares

Expires 2029-06-01

F1 · derivative.exercise_date: The stock option was granted on June 1, 2019 and becomes exercisable in three equal annual installments beginning on June 1, 2020.

SEC source: 0001567619-19-012274 · doc1.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,708

F1 · security: Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company.

SEC source: 0001567619-18-005431 · doc1.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,972

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.34 to $69.27, inclusive.

SEC source: 0001019056-18-000784 · harsanyi_4.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2028-05-31

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on May 31, 2019.

SEC source: 0001140361-18-025560 · doc1.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,972

F1 · security: Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the day prior to the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date.

SEC source: 0001140361-17-045556 · doc1.xml · nonDerivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,077

F1 · security: Consists of vested restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended and restated.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.35 to $42.59, inclusive.

SEC source: 0001019056-17-000545 · harsanyi_4.xml · derivative · entry 1

Harsanyi Zsolt · CIK 0001380184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2027-05-31

F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on June 1, 2018.